In its latest announcement under the federal Modern Manufacturing Initiative, the government has funneled $61.2 million into a cancer drug project. The co-funded grants come under the collaboration stream of the $1.3 billion Modern Manufacturing Initiative (MMI) will support the $185 million Precision Oncology Screening Platform enabling Clinical Trials (PrOSPeCT). The project is being led…

The post Genomic cancer research gets $61.2 million federal boost appeared first on InnovationAus.com.

This post was originally published on InnovationAus.com.